Login to Your Account

Incyte's Reverset Finds Place Among Soldiers In AIDS Battle

By Randall Osborne

Monday, August 1, 2005

Though mostly off the front pages these days, the war against HIV goes on - and last week a new therapeutic recruit showed some of its colors, as Incyte Corp. unveiled data from a Phase IIb trial with the once-daily pill Reverset, yet another nucleoside analogue reverse transcriptase inhibitor (NRTI).

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription